ARTICLE | Clinical News
Supratek preclinical data
March 12, 2001 8:00 AM UTC
Supratek Pharma Inc., Montreal, Quebec Product: SP1017 Indication: Increase efficiency of DNA vaccine delivery Supratek reported that a DNA melanoma vaccine formulated with SP1017 increased survival ...